| 37.28 Delayed Data As of Nov 15 |  +0.73 / +2.00%Today’s Change | 33.97 Today|||52-Week Range 46.47 | -14.59% Year-to-Date |
| Amarin's Stock Could Reach $50 Per Share Soon Nov 13 / MotleyFool.com - Paid Partner Content | 3 Top Healthcare Stocks to Buy Now Nov 07 / MotleyFool.com - Paid Partner Content |
| Why Does AbbVie Pay a Much Higher Dividend Than Its Peers? Nov 13 / MotleyFool.com - Paid Partner Content | Why the Opioid Crisis Makes Vertex Pharmaceuticals a Buy Nov 06 / MotleyFool.com - Paid Partner Content |
| Here's Why Solid Biosciences Collapsed Today Nov 12 / MotleyFool.com - Paid Partner Content | What's Behind OPKO Health's Lackluster Q3 Performance Nov 06 / MotleyFool.com - Paid Partner Content |
| Previous close | 36.55 |
| Today’s open | 36.63 |
| Day’s range | 36.52 - 37.47 |
| Volume | 34,515,591 |
| Average volume (3 months) | 22,992,408 |
| Market cap | -- |
| Earnings growth (last year) | -46.78% |
| Earnings growth (this year) | -1.77% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | +2.10% |
| P/E ratio | 13.0 |
| Price/Sales | 4.86 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.53 | +0.59% |
| MRKMerck | +0.35 | +0.41% |
| ABBVAbbVie | +1.00 | +1.14% |
| AZNAstraZeneca | +0.07 | +0.15% |
| Next reporting date | January 28, 2020 |
| EPS forecast (this quarter) | $0.57 |
| Annual revenue (last year) | $53.6B |
| Annual profit (last year) | $11.2B |
| Net profit margin | 20.77% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
